The treatment of coronary artery disease has changed over the past 35 years since the
introduction of coronary artery bypass surgery in 1968. Percutaneous coronary intervention …

The role of percutaneous coronary intervention (PCI) in the treatment of multivessel coronary
artery disease remains intensely debated and highly editorialized. Although an increasing …

Multivessel coronary artery disease is more often treated either with coronary artery bypass
surgery (CABG) or percutaneous coronary intervention (PCI) with stenting. The advent of …

Objectives: We performed the long-term (5-year) follow-up of a large cohort of patients who
underwent drug-eluting stent (DES) or coronary artery bypass graft (CABG) surgery for …

BACKGROUND: The introduction of drug-eluting stents (DESs) has demonstrated
superiority over the bare metal stent in reducing the incidence of restenosis. We investigated …

The Arterial Revascularisation Therapies Study (ARTS) was designed to compare CABG
and stenting in patients with multi-vessel disease. 8 In total, 1205 patients from 67 …

Drug-eluting stents (DES) constitute a major breakthrough in restenosis prevention after
initial percutaneous coronary intervention (PCI). Target lesion and vessel revascularization …

Background—Although previous studies have compared the treatment effects of
percutaneous coronary intervention and coronary artery bypass grafting (CABG), the long …

Background Restenosis and a high incidence of new revascularisations reduce the long-
term efficacy of percutaneous coronary intervention (PCI) in patients with multivessel …

There have been attempts to find new approaches to the treatment of multivessel coronary
artery disease without increasing adverse events. Deployment of drug-eluting stents (DES) …